Proprius Pharmaceuticals licenses, develops and commercializes pharmaceutical products in the Rheumatology and Autoimmune Disease markets. With the purpose of individualizing care in these areas, we also create and market proprietary, high-value clinical laboratory tests. This novel combination provides a differentiated approach to commercialization.
The core capabilities of Proprius Pharmaceuticals extend from clinical development and regulatory approval through commercialization.
The Proprius Pharma management team has an excellent track record of successful development, launch, growth, repositioning, and turnaround of pharmaceuticals products.
Proprius is actively pursuing partnerships to develop and commercially support pharmaceutical and diagnostic products to address unmet clinical needs. Our business development activities are concentrated within the focus areas of rheumatology and autoimmune diseases, and may include:
- Therapeutics marketed in the US
- Therapeutics marketed outside the US
- With a dossier supportive of an NDA
- Therapeutics in late-stage development
- Phase II+
- With data supportive of clinical value
- Strategic company acquisitions
We will consider in-licensing, acquisition, co-promotion, revenue-sharing and other collaboration arrangements. If you would like to discuss a potential partnership with Proprius Pharmaceuticals, please send an e-mail to: